Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How crystals damage tissue.

Eamonn S Molloy1, Geraldine M McCarthy

  • 1Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland.

Current Rheumatology Reports
|May 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

The OMERACT core domain sets for calcium pyrophosphate deposition disease.

Seminars in arthritis and rheumatism·2026
Same author

Rapid access microscopy and real-time case discussion via a secure messaging app improves diagnostic accuracy and management of acute hot swollen joints.

BMJ open quality·2025
Same author

Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus.

Seminars in arthritis and rheumatism·2025
Same author

Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus.

Seminars in arthritis and rheumatism·2025
Same author

A Novel Polarized Light Microscope for the Examination of Birefringent Crystals in Synovial Fluid.

Gout, urate, and crystal deposition disease·2025
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Common crystals like basic calcium phosphate (BCP) and calcium pyrophosphate dihydrate (CPPD) cause joint disease. Emerging research links BCP crystals to breast cancer and atherosclerosis, advancing therapy development.

Area of Science:

  • Biochemistry
  • Pathology
  • Immunology

Background:

  • Basic calcium phosphate (BCP), calcium pyrophosphate dihydrate (CPPD), and monosodium urate (MSU) crystals are implicated in human diseases.
  • While known for joint diseases, BCP crystals are increasingly linked to breast cancer and atherosclerosis.
  • Crystal-induced tissue damage involves proteases, cytokines, chemokines, and prostanoids.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of crystal-induced pathologies.
  • To highlight the role of BCP and CPPD crystals in non-joint diseases.
  • To underscore the importance of these advances for developing new therapies.

Main Methods:

  • Literature review of recent scientific publications.

Related Experiment Videos

  • Analysis of molecular pathways involved in crystal-mediated cellular responses.
  • Synthesis of evidence linking crystal types to specific diseases.

    • Main Results:

    • BCP and CPPD crystal-induced responses are amplified by mitogenesis-driven cellular proliferation.
    • Molecular mechanisms underlying crystal-induced pathology are increasingly understood.
    • New associations between BCP crystals and conditions like breast cancer and atherosclerosis have been identified.

    Conclusions:

    • Advances in understanding crystal-associated disease mechanisms are crucial.
    • Targeting molecular pathways may lead to novel therapeutic strategies.
    • Further research into BCP and CPPD crystal roles in systemic diseases is warranted.